# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Through this arrangement, Cogent will initially launch its newly developed CBD lozenge on Aurora's Canadian medical cannabi...
EPA grants $6.2M to Hemp Building Institute to boost hempcrete use in construction, aligning with Biden's climate goals. Re...
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has scheduled a conference call to discuss the results for its first quarter 2025...